Cite

HARVARD Citation

    Barthelemy, P. et al. (n.d.). 878PTiNivo - tivozanib combined with nivolumab: Safety and efficacy in patients with metastatic renal cell carcinoma (mRCC). Annals of oncology. p. . [Online]. 
  
Back to record